Document Detail


Outcome after autologous hemopoietic stem cell transplantation in relapsed or refractory childhood Hodgkin disease.
MedLine Citation:
PMID:  15543009     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To determine the clinical outcome and prognostic factors for overall survival in children with recurrent and/or primary refractory Hodgkin disease (HD) after high-dose therapy and autologous hemopoietic stem cell transplantation (AHSCT). The survival outcome of this treatment was compared with conventional salvage therapy without stem cell transplantation.
METHODS: Clinical records of 51 patients with relapsed or refractory HD who underwent AHSCT were reviewed. The source of the stem cells was bone marrow (n = 22) or peripheral blood (n = 29). At the time of high-dose therapy, 39 patients were in complete remission and 1 was in partial remission, while the remaining 11 had refractory disease. The records of 78 patients from the HD 1 trial who underwent conventional salvage treatment but without AHSCT for relapsed or refractory HD were also reviewed. All patients received HDT without radiation for conditioning.
RESULTS: Overall survival from diagnosis of patients treated with AHSCT did not differ significantly from that of those treated with conventional salvage therapy (hazard ratio = 1.5; 95% confidence interval = 0.9-8.2; P = 0.4). There were also no statistically significant differences in survival data between the two approaches for patients whose duration of first remission was less than or greater than 1 year (P = 0.5; stratified log-rank). Of the 11 patients who received AHSCT for refractory disease, 9 remain alive and well with followups ranging from 2 to 18 years. No deaths due to treatment-related complications were seen in the AHSCT group.
CONCLUSIONS: Stem cell transplantation does not offer any significant survival advantage over conventional salvage therapy in children with relapsed HD, although it may be of benefit for patients with primary refractory disease.
Authors:
Sara Stoneham; Sue Ashley; C Ross Pinkerton; W Hamish Wallace; Ananth Gouri Shankar;
Related Documents :
18415659 - Radioimmunotherapy with [188re]-labelled anti-cd66 antibody in the conditioning for all...
16151429 - Okt3 muromonab as second-line and subsequent treatment in recipients of stem cell allog...
18454459 - Characterization of acute graft-versus-host disease following reduced-intensity stem-ce...
2070129 - Bone marrow transplantation for chronic lymphocytic leukemia.
2697589 - Allogeneic bone marrow transplantation in patients with multiple myeloma.
17116129 - Combination chemotherapy followed by autologous stem cell transplant for enteropathy-as...
18204259 - Palliative radiation therapy for advanced gastrointestinal cancer.
6492809 - A technique for isolated hyperthermic liver perfusion.
22763029 - Discordance between preoperative and postoperative bladder cancer location: implication...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of pediatric hematology/oncology     Volume:  26     ISSN:  1077-4114     ISO Abbreviation:  J. Pediatr. Hematol. Oncol.     Publication Date:  2004 Nov 
Date Detail:
Created Date:  2004-11-15     Completed Date:  2004-12-21     Revised Date:  2011-10-06    
Medline Journal Info:
Nlm Unique ID:  9505928     Medline TA:  J Pediatr Hematol Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  740-5     Citation Subset:  IM    
Affiliation:
Department of Paediatric Haematology & Oncology, The Royal London Hospital, Whitechapel, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Child
Child, Preschool
Drug Resistance, Neoplasm
Female
Hematopoietic Stem Cell Transplantation / methods*,  mortality
Hodgkin Disease / mortality,  therapy*
Humans
Male
Prognosis
Recurrence
Retrospective Studies
Salvage Therapy / methods*
Survival Analysis
Transplantation, Autologous
Treatment Outcome
Comments/Corrections
Comment In:
J Pediatr Hematol Oncol. 2006 Nov;28(11):772   [PMID:  17114969 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cerebellar ataxia in pediatric patients with Langerhans cell histiocytosis.
Next Document:  A comprehensive study of the neonatal manifestations of congenital dyserythropoietic anemia type I.